GLP-1 drugs and PCOS insulin resistance: what TikTok gets wrong

What did @haleighweaver5 actually say?

In a short TikTok aimed at people with PCOS using Ozempic (semaglutide), @haleighweaver5 offered five tips for success, though the video cuts off before tip five. The three she landed on: rotate your injection site to avoid plateaus and different side effects, eat enough protein or "your body goes into starvation mode," and move your body, even if it's just walking. Straightforward advice, mostly. But some of it deserves a closer look.

Her framing is casual and personal, the kind of thing you'd hear from a friend who's three months into treatment. That's fine for community support. It gets trickier when physiological claims get mixed in, specifically the starvation mode argument and the idea that injection site rotation prevents plateaus on GLP-1 therapy.

Does the science back this up?

Partially, yes. The protein and exercise advice is well-supported. The injection rotation claim is partially correct but overstated. The starvation mode framing is the weakest link here.

On injection rotation: the FDA prescribing information for semaglutide does recommend rotating injection sites, and there is real variation in subcutaneous absorption between the abdomen, thigh, and upper arm. A 2021 review by Heise et al. in Diabetes, Obesity and Metabolism confirmed that injection site affects insulin absorption, and similar principles apply to GLP-1 agonists. But connecting rotation to preventing weight loss plateaus is a leap the current evidence doesn't support. Plateaus on semaglutide are driven by adaptive metabolic responses and dose titration, not injection geography.

On protein: the concern about muscle loss during GLP-1-assisted weight loss is legitimate. A 2023 study by Wilding et al. in The Lancet noted that lean mass loss accompanies fat loss on semaglutide, making protein intake and resistance exercise genuinely important. The "starvation mode" label, however, is an oversimplification that conflates a real issue with a pop-science concept.

What did they get wrong (or right)?

Let's give credit where it's due. The core advice here is not wrong. Eating enough protein, staying active, and rotating injection sites are all reasonable, evidence-adjacent recommendations for anyone on a GLP-1 agonist.

Where she goes off track is the mechanism. Saying rotation helps "ensure you don't plateau" implies a causal link that isn't established. Weight loss plateaus on semaglutide are complex. They involve adaptive thermogenesis, hormonal feedback, and sometimes dose saturation. No study has shown that injection site rotation breaks or prevents these plateaus.

The "starvation mode" framing for inadequate protein is also worth pushing back on. The clinical concern is real: GLP-1 agonists suppress appetite significantly, and some patients under-eat protein, leading to accelerated lean mass loss. But "starvation mode" as a concept, where the body hoards fat because you didn't eat enough, is not a clinically defined phenomenon. The actual risk is muscle catabolism, not metabolic shutdown. Misframing this can mislead people into thinking eating more will automatically fix a plateau.

Her exercise advice is genuinely good and undersells itself. Walking and light movement during GLP-1 therapy has been shown to improve body composition outcomes. She's right, and she didn't overclaim it.

What should you actually know?

If you're on a GLP-1 agonist for PCOS-related weight management, the practical advice in this video is mostly pointing in the right direction, even if some of the reasoning behind it is shaky.

Protein matters. A 2022 paper by Koliaki et al. in Nutrients recommends 1.2 to 1.6 grams of protein per kilogram of body weight during caloric restriction to preserve lean mass. GLP-1 therapy often cuts appetite so aggressively that hitting this target requires intentional effort.

Movement matters. Resistance training in particular, not just steps, has the best evidence for preserving muscle during weight loss. Walking is a great starting point, but it shouldn't be the ceiling.

Injection rotation is recommended clinical practice, but do not expect it to fix a plateau. If your weight loss has stalled, that's a conversation for your prescribing clinician about dose, diet adequacy, or whether something else is going on metabolically, particularly relevant in PCOS where insulin resistance and androgen levels complicate the picture.

Finally, "starvation mode" is not a diagnosis. If you're losing hair or muscle on a GLP-1, the issue is likely inadequate protein or calories, not a mysterious metabolic shutdown. Work with a registered dietitian if you can.